Neuroglow

At, we partner with mental health providers to deliver cutting-edge, evidence-based therapies, including SPRAVATO® (FDA-approved and insurance-backed esketamine therapy) and ketamine infusions. These treatments offer your patients new hope when traditional approaches fall short. Why Partner with NeuroGlow: We collaborate closely with referring providers to ensure a seamless experience for you and your patients. Our personalized treatment plans integrate with your care to support your patients’ recovery and well-being: Your patients will receive compassionate, evidence-based care from a highly skilled medical team, specializing in SPRAVATO® and ketamine therapies to ensure the highest safety and efficacy: As an insurance-backed provider of SPRAVATO®, we offer patients an affordable option for treatment-resistant depression while guiding them through the approval and reimbursement process: Our team is highly trained in administering advanced therapies to deliver transformative results for conditions such as treatment-resistant depression, PTSD, anxiety, and chronic pain: We keep referring providers informed at every stage, offering updates on patient progress and ensuring continuity of care: Our therapies are designed to provide rapid relief, lasting mental clarity, and improved quality of life for your patients. Let’s Collaborate to Change Lives Together, we can help patients achieve healing and hope through innovative therapies like SPRAVATO® and ketamine. To refer a patient or learn more about our collaborative process, visit our website or contact us today.